The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia

Pusan National University

Status: Completed

Conditions: Androgenic Alopecia

Treatments: Other: stem cell component extract

Study type: Interventional

Funder types: Other

Identifiers

NCT02594046

L-2015-199-2

Details and patient eligibility

About

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.

Full description

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.

Enrollment: 38 patients

Sex: All

Ages: 19 to 59 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher

Exclusion criteria

• patient of scalp disease

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

38 participants in 2 patient groups, including a placebo group

stem cell group

Experimental group

Description:

stem cell group who apply 1.2 g of allogeneic human adipose derived stem cell component extract on their scalp for 16 weeks

Treatment:

Other: stem cell component extract

placebo group

Placebo Comparator group

Description:

placebo group who apply a placebo on their scalp for 16 weeks

Treatment:

Other: stem cell component extract